Skip to main content
Milestones in Drug Therapy

Treatment of bipolar disorder in special populations

Publication ,  Chapter
Beyer, JL; Krishnan, KRR
January 1, 2016

Though often considered a young person’s disease because its mean age of onset is in late adolescence, bipolar disorder (BD) frequently demonstrates recurrent episodes and morbidities that continue throughout the lifetime of the patient and into old age. In fact, presentation of mood episodes in older age is quite common and requires clinicians to understand the unique challenges that the interaction of aging and mental illness present. Further, it has been well established that the depressive polarity of episodes increases in frequency over the life span with a decline in manic and mixed episode presentations. Finally, while new onset of illness is relatively rare in later ages, it is not unknown, and the variability of age of onset may allow for a better understanding of the disease process. This chapter reviews our current understanding of BD in the elderly and highlights the implications of age in understanding the heuristic causes of the disease, challenges to treatment, and the limitations of our knowledge for clinical care.

Duke Scholars

DOI

Publication Date

January 1, 2016

Start / End Page

289 / 313
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Beyer, J. L., & Krishnan, K. R. R. (2016). Treatment of bipolar disorder in special populations. In Milestones in Drug Therapy (pp. 289–313). https://doi.org/10.1007/978-3-319-31689-5_13
Beyer, J. L., and K. R. R. Krishnan. “Treatment of bipolar disorder in special populations.” In Milestones in Drug Therapy, 289–313, 2016. https://doi.org/10.1007/978-3-319-31689-5_13.
Beyer JL, Krishnan KRR. Treatment of bipolar disorder in special populations. In: Milestones in Drug Therapy. 2016. p. 289–313.
Beyer, J. L., and K. R. R. Krishnan. “Treatment of bipolar disorder in special populations.” Milestones in Drug Therapy, 2016, pp. 289–313. Scopus, doi:10.1007/978-3-319-31689-5_13.
Beyer JL, Krishnan KRR. Treatment of bipolar disorder in special populations. Milestones in Drug Therapy. 2016. p. 289–313.

DOI

Publication Date

January 1, 2016

Start / End Page

289 / 313